WallStreetZenWallStreetZen

NASDAQ: SPRY
Ars Pharmaceuticals Inc Stock Ownership - Who owns Ars Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ars Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brian DorseyChief Operating Officer2025-11-1321,828$0.64
$13.97kBuy
Brian DorseyChief Operating Officer2025-11-1321,828$8.71
$190.06kSell
Justin ChakmaChief Business Officer2025-11-1230,000$0.84
$25.20kBuy
Justin ChakmaChief Business Officer2025-11-1230,000$8.91
$267.36kSell
Justin ChakmaChief Business Officer2025-11-12136,380$8.86
$1.21MSell
Kathleen D. ScottChief Financial Officer2025-08-2112,500$1.50
$18.75kBuy
Kathleen D. ScottChief Financial Officer2025-08-2112,500$15.00
$187.50kSell
Richard E. LowenthalPRESIDENT AND CEO2025-08-2150,000$14.49
$724.35kSell
Sarina TanimotoCHIEF MEDICAL OFFICER2025-08-2037,656$14.09
$530.61kSell
Sarina TanimotoCHIEF MEDICAL OFFICER2025-08-1912,344$14.03
$173.12kSell

1 of 4

SPRY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SPRY insiders and whales buy or sell their stock.

SPRY Shareholders

What type of owners hold Ars Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Richard E. Lowenthal22.21%21,952,529$220.84MInsider
Sarina Tanimoto20.60%20,360,336$204.82MInsider
Orbimed Advisors LLC17.23%17,029,398$171.32MInsider
Peter A. Thompson17.23%17,029,398$171.32MInsider
Ra Capital Management LP10.99%10,860,977$109.26MInstitution
James E. Flynn9.89%9,774,508$98.33MInsider
Orbimed Advisors LLC8.39%8,288,510$83.38MInstitution
Deerfield Management Company LP7.59%7,503,812$75.49MInstitution
Blackrock Inc4.89%4,831,327$48.60MInstitution
Rubric Capital Management LP4.55%4,500,000$45.27MInstitution

1 of 3

SPRY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SPRY44.43%55.57%Net SellingNet Selling
GHRS71.79%0.00%
BBOT62.58%37.42%Net Buying
VTYX40.55%59.45%Net SellingNet Selling
CAPR27.03%72.97%Net BuyingNet Buying
View Top Biotech Stocks

Ars Pharmaceuticals Stock Ownership FAQ

Who owns Ars Pharmaceuticals?

Ars Pharmaceuticals (NASDAQ: SPRY) is owned by 84.61% institutional shareholders, 105.81% Ars Pharmaceuticals insiders, and 0.00% retail investors. Richard E. Lowenthal is the largest individual Ars Pharmaceuticals shareholder, owning 21.95M shares representing 22.21% of the company. Richard E. Lowenthal's Ars Pharmaceuticals shares are currently valued at $224.35M.

If you're new to stock investing, here's how to buy Ars Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.